天然产物研究与开发 ›› 2026, Vol. 38 ›› Issue (9): 1881-1890.doi: 10.16333/j.1001-6880.2026.9.002 cstr: 32307.14.1001-6880.2026.9.002

• 研究论文 • 上一篇    下一篇

基于NRF2 / SLC7A11 / GPX4 通路探讨白芍总苷调控铁死亡改善2 型糖尿病大鼠肝损伤的作用及机制

王文佳 1,葛  文 1,韩慧子 1,柯尊丽 1,田维毅 1,2∗,俞  琦 1,3∗
  

  1. 1贵州中医药大学基础医学院,贵阳550025; 2贵阳康养职业大学,贵阳550081;3 贵州护理职业技术学院,黔南布依族苗族自治州551304

  • 出版日期:2026-09-24 发布日期:2026-09-22
  • 基金资助:

    国家自然科学基金(82460858);贵州省科技计划项目(黔科合平台KXJZ[2024]034);贵州中医药大学国家与省级科技创新人才团队培育项目(贵中医TD 合字[2023]002 号)

Total glucosides from Paeoniae Radix Alba ameliorate liver injury in type 2 diabetic rats by inhibiting ferroptosis via the NRF2 / SLC7A11 / GPX4 signaling pathway

WANG Wen-jia1,GE Wen1,HAN Hui-zi1,KE Zun-li1,TIAN Wei-yi1,2 ∗,YU Qi1,3 ∗   

  1. 1School of Basic Medical Sciences,Guizhou University of Traditional Chinese Medicine, Guiyang 550025,China;2Guiyang Nursing Vocational University,Guiyang 550081,China; 3Guizhou Nursing Vocational College,Qiannan Buyi and Miao Autonomous Prefecture 551304,China

  • Online:2026-09-24 Published:2026-09-22

摘要:

探讨白芍总苷(total glucosides from Paeoniae Radix Alba,TGP)调控核因子E2 相关因子2(nuclear factor erythroid 2-related factor 2,NRF2) / 溶质载体家族7 成员11(solute carrier family 7 member 11,SLC7A11) / 谷胱甘肽过氧化物酶4(glutathione peroxidase 4,GPX4)通路抑制肝细胞铁死亡改善2 型糖尿病(type 2 diabetes mellitus,T2DM)大鼠肝损伤的作用及机制。采用T2DM 模型大鼠为实验对象,将其随机分为模型组、二甲双胍组、TGP(50 mg/ kg)组、TGP (100 mg/ kg)组和TGP(200 mg/ kg)组,另设对照组,用药物或蒸馏水灌胃干预4 周。检测空腹血糖(fasting blood glucose,FBG);计算肝脏指数;采用生化法检测谷丙转氨酶(alanine aminotransferase,ALT)、谷草转氨酶(aspartate aminotransferase,AST)、甘油三酯(triglyceride,TG)、总胆固醇(total cholesterol,TC)、低密度脂蛋白胆固醇(low-density lipoprotein cholesterol,LDL-C)、高密度脂蛋白胆固醇(high-density lipoprotein cholesterol,HDL-C);组织病理学评价肝损伤;比色法检测超氧化物歧化酶(superoxide dismutase,SOD)、丙二醛(malondialdehyde,MDA)、谷胱甘肽(glutathione, GSH)和Fe2 + ;Western blot 检测转铁蛋白受体1(transferrin receptor 1,TFR1)、铁转运蛋白1(ferroportin 1,FPN1)、 NRF2、SLC7A11 和GPX4 蛋白;RT-qPCR 检测相关基因表达。结果表明,与对照组比较,模型组大鼠FBG、肝脏指数、 ALT、AST、TG、TC、LDL-C 及MDA 水平均显著升高(P < 0. 01),HDL-C、SOD 和GSH 显著降低(P < 0. 01);肝脏组织出现脂质沉积及脂毒性炎症损伤;肝脏Fe2 + 含量和TFR1 表达升高(P < 0. 01),FPN1、NRF2、SLC7A11 和GPX4 蛋白明显下调(P < 0. 01),NRF2、SLC7A11、GPX4 mRNA 表达水平显著降低(P < 0. 01)。与模型组相比,TGP 高剂量能明显降低模型大鼠FBG 水平(P < 0. 05);TGP 中、高剂量组大鼠肝脏指数、ALT、AST、TG、TC 和LDL-C 水平均明显下降(P < 0. 05,P < 0. 01),HDL-C 显著升高(P < 0. 01),肝脏病理损伤和脂肪变性不同程度减轻,MDA 表达明显下降(P < 0. 01),SOD 和GSH 表达显著上升(P < 0. 01),NRF2、SLC7A11、GPX4 蛋白水平明显升高(P < 0. 01),TGP 高剂量能显著上调NRF2、SLC7A11 和GPX4 的mRNA 表达(P < 0. 01);TGP 各剂量组Fe2 + 含量均显著下降(P < 0. 01),FPN1 表达均显著升高(P < 0. 01),中、高剂量组TFR1 显著下降(P < 0. 01)。TGP 具有改善2 型糖尿病大鼠血糖水平及肝损伤作用,其机制可能与其激活肝脏NRF2 / SLC7A11 / GPX4 通路抑制铁死亡有关。

关键词:

"> 白芍总苷, 脂质过氧化, 糖尿病肝损伤, NRF2 / SLC7A11 / GPX4 通路, 铁死亡

Abstract:

This study aimed to investigate the protective effect of total glucosides from Paeoniae Radix Alba (TGP) against liver injury in rats with type 2 diabetes mellitus (T2DM) by regulating of the nuclear factor erythroid 2-related factor 2 (NRF2) / solute carrier family 7 member 11 (SLC7A11) / glutathione peroxidase 4 (GPX4) signaling pathway to inhibit hepatocyte ferroptosis. Using T2DM model rats as experimental subjects,and the animals were randomly divided into control group,model group,metformin group,and TGP (50,100,and 200 mg/ kg) groups. They were treated with the corresponding drugs or distilled water by oral gavage for four weeks. Fasting blood glucose (FBG) and liver indexs were tested,and the biochemical method is used to detect alanine aminotransferase (ALT),aspartate aminotransferase (AST),triglycerides (TG), total cholesterol ( TC), low-density lipoprotein cholesterol ( LDL-C), and high-density lipoprotein cholesterol ( HDL-C) . Histopathological changes were evaluated. Superoxide dismutase (SOD),malondialdehyde (MDA),glutathione (GSH),and Fe2 + levels were detected by colorimetric assay. The protein expressions of transferrin receptor 1 ( TFR1), ferroportin 1 (FPN1) ,NRF2,SLC7A11,and GPX4 were assessed with Western blot,and their gene expressions were checked by RTqPCR. Compared with the control group,the model group showed significantly elevated levels of FBG,liver index,ALT,AST, TG,TC,LDL-C and MDA (P < 0. 01),and significantly decreased levels of HDL-C,SOD and GSH (P < 0. 01). Lipid deposition and lipotoxic inflammatory injury were observed in liver tissue. The hepatic Fe2 + content and TFR1 expression were increased (P < 0. 01),while the protein expressions of FPN1,NRF2,SLC7A11 and GPX4 were significantly down-regulated (P < 0. 01),and the mRNA expression levels of NRF2,SLC7A11 and GPX4 were markedly reduced (P < 0. 01). Compared with the model group,High-dose TGP markedly reduced FBG levels in model rats (P < 0. 05). In the medium- and high-dose TGP groups,the liver index and levels of ALT,AST,TG,TC,and LDL-C were significantly decreased (P < 0. 05,P < 0. 01),while HDL-C was notably increased (P < 0. 01). Hepatic pathological injury and steatosis were alleviated to varying degrees;MDA expression was significantly decreased (P < 0. 01),and SOD and GSH expressions were markedly elevated (P < 0. 01). The protein levels of NRF2,SLC7A11,and GPX4 were significantly upregulated ( P < 0. 01) . High-dose TGP significantly increased the mRNA expressions of NRF2, SLC7A11,and GPX4 (P < 0. 01). In all TGP-treated groups,Fe2 + content were significantly reduced (P < 0. 01) and FPN1 expression was markedly increased (P < 0. 01);TFR1 was significantly decreased in the medium- and high-dose groups (P < 0. 01). TGP can improve hyperglycemia and liver injury in T2DM rats,and the mechanism may involve in activating the NRF2 / SLC7A11 / GPX4 signaling pathway and therefore to inhibit ferroptosis.

Key words:

"> total glucosides from Paeoniae Radix Alba, lipid peroxidation, diabetic liver injury, NRF2 / SLC7A11 / GPX4 pathway, ferroptosis

中图分类号: 

R285. 5 ','1');return false;" target="_blank"> "> R285. 5